查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363531

尿道結石管理設備市場規模、佔有率和趨勢分析報告：按治療類型、最終用途、地區和細分市場分類的趨勢，2023-2030 年

Urolithiasis Management Devices Market Size, Share & Trends Analysis Report By Treatment Type (Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 115 Pages | 商品交期: 2-10個工作天內

價格

尿道結石管理設備市場成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球尿道結石管理設備市場價值將達到 22.1 億美元。

預計2023年至2030年年複合成長率為4.9%。多年來，尿道結石罹患率的驚人增加導致了治療方案的進步。歐洲泌尿系統協會指出，尿道結石是最常見的與文明病之一，患病10%，需要系統性的治療方法。

尿道結石是指泌尿器官系統中結石的形成，主要包括腎臟、輸尿管和膀胱。尿道結石是美國、加拿大、德國等高階國家的主要醫療保健問題，大多數情況下復發率為50%。尿道結石可以透過改變生活方式、用餐管理和基本藥物來控制。然而，為了取出引起劇烈疼痛的大結石，必須採用不同的治療方法。根據結石的大小、其在體內的位置以及泌尿生殖道的解剖變化，有侵入性和非侵入性的結石清除方法。例如，小結石可以透過體外震波碎石術（體外震波碾碎）移除，大結石可以透過手術移除（體外震波碾碎或經皮腎鏡取石術）。

小結石通常不需要手術干涉，可以透過藥物和健康用餐來治療。然而，隨著石頭越來越大，需要採取不同的方法來去除它。體外震波碎石術是常見的結石清除治療方法之一，在2015年佔據了大部分市場佔有率。體內碾碎是治療方法使用內視鏡發現並縮小結石尺寸的治療方法。使用超音波或雷射技術來崩壞結石，使較小的碎片能夠通過泌尿系統。由於其高無石率，體腔內碾碎可能是預測期內的首選治療選擇。

此外，經皮腎鏡取石手術是一種在體外或體內碾碎無效時移除較大結石的手術方法，通常需要住院一週。

門診手術中心越來越受歡迎，因為它們比傳統醫院和診所節省時間和金錢。因此，預計該最終用途領域在預測期內將出現良好的成長率。引入新的手術技術，如內視鏡和微型配件（包括導絲、手術刀和籃子），可以快速有效地從泌尿系統中排放結石，將提高微創手術的整體可接受性，而且還在不斷增加。

尿道結石管理設備市場報告亮點

  • 尿道結石在全世界範圍內非常普遍，佔全球目標人口的 15%，復發率為 50%。男性比女性更容易罹患腎結石。
  • 體內碾碎細分市場佔據主導地位，2022 年收益佔有率最高，為 34.6%，預計在預測期內將以 6.8% 的最快年複合成長率成長。體內碾碎使用內視鏡觀察結石，並使用雷射同時將其分解成易於處理的碎片。
  • 在已開發國家，人們擴大採用久坐的生活方式，加上不健康食品的消費增加，導致腎結石發病率不斷上升。門診手術服務提供者的治療需求預計將激增，特別是由於已開發國家不健康的生活方式的改變。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 結石管理設備市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 尿道結石管理裝置市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 結石管理裝置：治療類型估計與趨勢分析

  • 尿道結石管理設備市場：重點
  • 尿道結石管理設備市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 體外震波碾碎（ESWL）
    • 體外震波碾碎
  • 體內碎石術
    • 2018年至2030年體內碾碎市場估計與預測
  • 經皮經皮
    • 2018年至2030年經皮腎鏡取石術市場估計與預測
  • 其他治療方法
    • 2018年至2030年其他治療方法市場估計與預測

第5章 結石管理裝置：最終用途估算與趨勢分析

  • 尿道結石管理設備市場：重點
  • 尿道結石管理設備市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 醫院和診所
  • 日間手術中心 (ASC)

第6章 結石管理設備市場：區域估計與趨勢分析

  • 區域預測
  • 按地區分類的尿道結石管理設備市場：要點
  • 北美洲
    • 2018-2030 年北美市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030 年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 2018-2030 年亞太市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 2018 年至 2030 年 MEA 市場估計與預測
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Allengers
    • Boston Scientific
    • BD
    • Cook Medical
    • ConMed
    • DirexGroup
    • Dornier MedTech
    • Potent Optotronic
    • HealthTronics
    • Karl Storz
    • Lumenis
    • Olympus
    • Richard Wolf
    • Siemens Healthcare
Product Code: GVR-1-68038-152-8

Urolithiasis Management Devices Market Growth & Trends:

The global urolithiasis management devices market was valued at USD 2.21 billion by 2030, according to a new report by Grand View Research, Inc.. It is expected to expand at a CAGR of 4.9% from 2023 to 2030. The alarming growth in the incidence rate of urinary stones, over the years, is responsible for the advancements in the treatment options. European Association of Urology states that it is one of the most common lifestyle disorders with a 10% prevalence rate and requires a systematic treatment approach.

Urolithiasis means formation of stones in the urinary system, mainly including the kidney, ureters, and the bladder. It is a major healthcare concern in the high end countries such as the U.S., Canada, and Germany with a recurrence rate of 50% in most of the cases. Urolithiasis can be managed with the help of lifestyle changes, controlled diet, or basic medication. However, various treatment approaches need to be adopted for the removal of large stones that cause severe pain. Depending upon the stone size, location in the body, and anatomical variations in the urogenital tract, invasive or noninvasive stone removal procedures are available. For instance, smaller stones can be tackled with external shock waves (extracorporeal shock wave lithotripsy), while larger stones can be removed through surgeries (intracorporeal lithotripsy or percutaneous nephrolithotomy).

Smaller stones generally do not require surgical interventions and can be cured with the help of medication and a healthy diet. However, larger stones necessitate different approaches for their elimination. Extracorporeal lithotripsy is one of the common treatments employed for stone elimination and held a majority market share in the year 2015. Intracorporeal lithotripsy treatments spot and reduce the stones to smaller pieces with the help of endoscopy. For the disintegration of stones, ultrasound or laser techniques are used to enable the passage of smaller fragments through the urinary system. Owing to the effective stone-free rate offered by intracorporeal lithotripsy, it is likely to be preferred as a treatment option during the forecast period.

Furthermore, percutaneous nephrolithotomy is a surgical approach deployed to eliminate larger stones where extracorporeal or intracorporeal lithotripsies prove to be ineffective and typically require a week's hospitalization.

Ambulatory surgical centers are gaining popularity over traditional hospital and clinic settings due to the time and cost saving benefits. As a result, this end-use segment is expected to record a lucrative growth rate during the forecast period. Introduction of novel surgical technologies, such as endoscopy and micro accessories including guidewires, scalpels, and baskets, to effectively expel stones from the urinary system in a short time has enhanced the overall acceptability of minimally invasive surgeries.

Urolithiasis Management Devices Market Report Highlights:

  • Urinary stones are highly prevalent worldwide with a 15% global target population and the recurrence rate of 50%. Men are more susceptible to developing renal stones than women.
  • The intracorporeal lithotripsy segment dominated the market and held the largest revenue share of 34.6% in 2022 and is expected to grow at the fastest CAGR of 6.8% over the forecast period. Intracorporeal lithotripsy involves the visualization of stones using an endoscope and their simultaneous disintegration into manageable fragments using lasers.
  • The upward trend in the adoption of sedentary lifestyle coupled with increased consumption of unhealthy food in the developed countries is responsible for the rising incidence of kidney stones. Ambulatory surgical service providers are expected to experience a surge in the treatment demand as a result of the unhealthy lifestyle changes, especially in the developed countries.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Treatment type
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Urolithiasis Management Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Urolithiasis Management Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Urolithiasis Management Devices: Treatment Type Estimates & Trend Analysis

  • 4.1. Urolithiasis Management Devices Market: Key Takeaways
  • 4.2. Urolithiasis Management Devices Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Extracorporeal Shock Wave Lithotripsy (ESWL)
    • 4.3.1. Extracorporeal shock wave lithotripsy (ESWL) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Intracorporeal Lithotripsy
    • 4.4.1. Intracorporeal lithotripsy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Percutaneous Nephrolithotomy
    • 4.5.1. Percutaneous nephrolithotomy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Other Treatments
    • 4.6.1. Other treatments market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Urolithiasis Management Devices: End Use Estimates & Trend Analysis

  • 5.1. Urolithiasis Management Devices Market: Key Takeaways
  • 5.2. Urolithiasis Management Devices Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals & Clinics
    • 5.3.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Ambulatory Surgical Centers (ASCs)
    • 5.4.1. Ambulatory surgical centers (ASCs) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Urolithiasis Management Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Urolithiasis Management Devices Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. UK
      • 6.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. France
      • 6.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. China
      • 6.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. India
      • 6.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Allengers
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Boston Scientific
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. BD
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Cook Medical
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. ConMed
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. DirexGroup
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Dornier MedTech
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Potent Optotronic
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. HealthTronics
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Karl Storz
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Lumenis
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Olympus
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Richard Wolf
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Siemens Healthcare
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 3 North America urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 6 U.S. urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 8 Canada urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 10 Europe urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 13 Germany urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 15 UK urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 17 France urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 19 Italy urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 21 Spain urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Sweden urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 23 Sweden urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Norway urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 25 Norway urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Denmark urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 27 Denmark urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 31 China urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 32 China urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Japan urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 34 Japan urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 36 India urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 38 Australia urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Thailand urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 40 Thailand urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 41 South Korea urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 42 South Korea urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 44 Latin America urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 47 Brazil urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 49 Mexico urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 51 Argentina urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 56 South Africa urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 60 UAE urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Urolithiasis management devices: Market outlook
  • Fig. 8 Urolithiasis management devices: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Urolithiasis management devices market driver impact
  • Fig. 14 Urolithiasis management devices market restraint impact
  • Fig. 15 Urolithiasis management devices market strategic initiatives analysis
  • Fig. 16 Urolithiasis management devices market: Treatment type movement analysis
  • Fig. 17 Urolithiasis management devices market: Treatment type outlook and key takeaways
  • Fig. 18 Extracorporeal shock wave lithotripsy (ESWL) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Intracorporeal lithotripsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Percutaneous nephrolithotomy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Other treatments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Urolithiasis management devices market: End use movement analysis
  • Fig. 23 Urolithiasis management devices market: End use outlook and key takeaways
  • Fig. 24 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Ambulatory surgical centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Global urolithiasis management devices market: Regional movement analysis
  • Fig. 27 Global urolithiasis management devices market: Regional outlook and key takeaways
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)